Molecular Characterization of the NLRC4 Expression in Relation to Interleukin-18 Levels

  • Tanja Zeller (Shared first author)
  • Tina Haase (Shared first author)
  • Christian Müller (Shared first author)
  • Helene Riess (Shared first author)
  • Denise Lau
  • Simon Zeller
  • Jasmin Krause
  • Jens Baumert
  • Ole Pless
  • Josée Dupuis
  • Philipp S Wild
  • Medea Eleftheriadis
  • Melanie Waldenberger
  • Sonja Zeilinger
  • Andreas Ziegler
  • Annette Peters
  • Laurence Tiret
  • Carole Proust
  • Carola Marzi
  • Thomas Munzel
  • Konstantin Strauch
  • Holger Prokisch
  • Karl J Lackner
  • Christian Herder
  • Barbara Thorand
  • Emilia J Benjamin
  • Stefan Blankenberg
  • Wolfgang Koenig
  • Renate B Schnabel

Abstract

BACKGROUND: Interleukin-18 (IL-18) is a pleiotropic cytokine centrally involved in the cytokine cascade with complex immunomodulatory functions in innate and acquired immunity. Circulating IL-18 concentrations are associated with type 2 diabetes mellitus, cardiovascular events, and diverse inflammatory and autoimmune disorders.

METHODS AND RESULTS: To identify causal variants affecting circulating IL-18 concentrations, we applied various omics and molecular biology approaches. By genome-wide association study, we confirmed association of IL-18 levels with a single nucleotide polymorphism in the untranslated exon 2 of the inflammasome component NLRC4 (NLR family, caspase recruitment domain-containing 4) gene on chromosome 2 (rs385076; P=2.4 × 10(-45)). Subsequent molecular analyses by gene expression analysis and reporter gene assays indicated an effect of rs385076 on NLRC4 expression and differential isoform usage by modulating binding of the transcription factor PU.1.

CONCLUSIONS: Our study provides evidence for the functional causality of single nucleotide polymorphism rs385076 within the NLRC4 gene in relation to IL-18 activation.

Bibliographical data

Original languageEnglish
ISSN1942-325X
DOIs
Publication statusPublished - 10.2015

Comment Deanary

© 2015 American Heart Association, Inc.

PubMed 26362438